BellRing Brands prepares to release its fourth-quarter financial results, with analysts forecasting a revenue dip. The report comes as investors gauge the resilience of the shelf-stable nutrition segment.
Archer-Daniels-Midland (ADM) is set to report Q4 earnings Tuesday morning. Analysts project a slight revenue dip, but investor sentiment remains cautiously optimistic as the agribusiness leader navigates a volatile global market.
Electrical systems specialist Powell Industries (NYSE:POWL) prepares to release its fourth-quarter results after Tuesday's market close, with investors weighing solid recent performance against a projected slowdown in revenue growth.
Benchmark Electronics (NYSE:BHE) is set to report Q4 earnings after Tuesday's market close, with analysts forecasting a return to revenue growth. The electronics manufacturing services provider enters the report on a strong note, having outperformed expectations last quarter.
Defense electronics specialist Mercury Systems (MRCY) is set to report quarterly results after Tuesday's close, with analysts projecting a revenue dip despite recent stock strength and positive industry tailwinds.
Packaging giant Ball Corporation (NYSE: BALL) is scheduled to release its quarterly earnings before Tuesday's market open. Investors are watching for signs of sustained growth as the industry navigates shifting demand and cost pressures.
The research and advisory giant is expected to post modest revenue growth when it reports Tuesday morning, as investors weigh its performance against a mixed backdrop for IT services firms.
The Northern Ireland Executive has suspended a planned revaluation of hotel business rates, averting significant tax increases for accommodation providers slated for 2026 and providing temporary stability for the region's tourism industry.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
Intuit expands its ecosystem with a dual-pronged strategy, launching a career development program for accounting students while integrating Checkr's background check services directly into its payroll and enterprise platforms, aiming to solidify its role from talent cultivation to HR operations.
The high-flying AI firm, now valued at $183 billion, has leased a 25-story tower in SoMa for a massive expansion, underscoring San Francisco's continued pull as a tech epicenter despite market shifts.
Deutsche Bank has upgraded NNN REIT to 'Buy' with a $47 price target, highlighting its defensive portfolio and sustainable dividends as relative strengths in a challenging real estate investment trust environment expected to persist through 2026.
U.S. oil giants ExxonMobil and Chevron hinted at a potential future role in Venezuela's energy revival during earnings calls, emphasizing the need for legal stability and clearer political outcomes before any major commitments. While sanctions ease and new legislation emerges, the path to significant investment remains long and fraught with uncertainty.
A dual shift in U.S. sanctions and Venezuelan oil law is unlocking the country's vast reserves for American companies, marking a potential turning point after decades of nationalization and economic isolation.
The U.S. Cotton Trust Protocol strengthens its executive team with two co-directors, while Arc'teryx creates a chief brand officer role, highlighting a strategic focus on traceability and consumer experience in a competitive market.
Omega Healthcare Investors (OHI) maintains its quarterly dividend, offering a signal of stability to income-focused shareholders as the healthcare REIT navigates tenant health and leverage concerns in a challenging operating environment.
Wix.com Ltd. has launched a major share repurchase program as its stock trades near multi-year lows. While analysts have trimmed price targets, many maintain bullish ratings, citing significant upside potential and a more resilient outlook for SaaS companies in the face of AI disruption.
Morgan Stanley reaffirms its Overweight rating on NIO Inc., maintaining a $7 price target. Analyst Tim Hsiao highlights the EV maker's plan for 40-50% annual delivery growth through 2026 and improved strategic focus following a meeting with founder William Li.
Ovid Therapeutics (NASDAQ: OVID) has garnered analyst optimism following positive Phase 1 trial results for its novel neurological drug candidate and a recent 'Outperform' initiation. The biotech firm is now shifting focus to a more potent oral therapy, with key regulatory milestones ahead.
While the sales and marketing software segment broadly exceeded revenue expectations in Q3, investor sentiment has turned sour, with most stocks falling post-earnings. We analyze the divergent performances of Upland Software, Sprinklr, DoubleVerify, PubMatic, and Sprout Social.
